Julia Chapman
Corporate Officer/Principal chez BridgeBio Pharma LLC
Profil
Julia Chapman is currently working as the Vice President of Business Development & Strategy at BridgeBio Pharma LLC.
Previously, she worked as the Senior Vice President of Corporate Strategy & Planning at Verve Therapeutics, Inc. Ms. Chapman completed her undergraduate degree and earned an MBA from Duke University.
Postes actifs de Julia Chapman
| Sociétés | Poste | Début |
|---|---|---|
BridgeBio Pharma LLC
 BridgeBio Pharma LLC BiotechnologyHealth Technology BridgeBio Pharma LLC engages in the discovery and development of pharmaceutical drugs for patients with genetic diseases. It offers transthyretin stabilizer, SHP2 inhibitor, KRAS inhibitor, Collagen 7 replacement, and S1P-lyase inhibitor. The company was founded by Neil Kumar and is headquartered in Palo Alto, CA. | Corporate Officer/Principal | - |
Anciens postes connus de Julia Chapman
| Sociétés | Poste | Fin |
|---|---|---|
| VERVE THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Formation de Julia Chapman
| Duke University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| VERVE THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
BridgeBio Pharma LLC
BridgeBio Pharma LLC BiotechnologyHealth Technology BridgeBio Pharma LLC engages in the discovery and development of pharmaceutical drugs for patients with genetic diseases. It offers transthyretin stabilizer, SHP2 inhibitor, KRAS inhibitor, Collagen 7 replacement, and S1P-lyase inhibitor. The company was founded by Neil Kumar and is headquartered in Palo Alto, CA. | Health Technology |
